WallStreetZenWallStreetZen

NASDAQ: COGT
Cogent Biosciences Inc Stock Ownership - Who owns Cogent Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cogent Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jessica SachsChief Medical Officer2025-12-2682,642$38.70
$3.20MSell
John Edward RobinsonChief Scientific Officer2025-12-2690,000$38.74
$3.49MSell
John L. GreenChief Financial Officer2025-12-2677,000$38.68
$2.98MSell
Evan KearnsChief Legal Officer2025-12-2665,000$38.70
$2.52MSell
John Edward RobinsonChief Scientific Officer2025-12-17139,998$39.45
$5.52MSell
Cole PinnowChief Commercial Officer2025-12-1794,800$39.45
$3.74MSell
John L. GreenChief Financial Officer2025-12-17145,007$39.45
$5.72MSell
Evan KearnsChief Legal Officer2025-12-17125,602$39.45
$4.95MSell
Andrew R. RobbinsPresident and CEO2025-12-17367,497$39.45
$14.50MSell
Jessica SachsChief Medical Officer2025-12-17154,716$39.45
$6.10MSell

1 of 2

COGT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when COGT insiders and whales buy or sell their stock.

COGT Shareholders

What type of owners hold Cogent Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC15.74%22,408,263$767.71MInstitution
Blackrock Inc7.28%10,369,535$355.26MInstitution
Deerfield Management Company LP6.36%9,053,118$310.16MInstitution
Fairmount Funds Management LLC6.32%9,003,418$308.46MInstitution
Fairmount Funds Management LLC6.32%9,003,418$308.46MInsider
Kynam Capital Management LP5.54%7,886,172$270.18MInstitution
Vanguard Group Inc5.45%7,757,662$265.78MInstitution
Commodore Capital LP5.09%7,250,000$248.39MInstitution
Tcg Crossover Management LLC4.77%6,798,162$232.91MInstitution
State Street Corp3.35%4,775,419$163.61MInstitution

1 of 3

COGT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
COGT90.15%9.85%Net BuyingNet Selling
CELC76.71%23.29%Net BuyingNet Selling
BLTE7.19%0.00%
PTGX82.76%17.24%Net SellingNet Selling
TGTX57.29%42.71%Net SellingNet Selling
View Top Biotech Stocks

Cogent Biosciences Stock Ownership FAQ

Who owns Cogent Biosciences?

Cogent Biosciences (NASDAQ: COGT) is owned by 111.83% institutional shareholders, 12.22% Cogent Biosciences insiders, and 0.00% retail investors. Fairmount Funds Management LLC is the largest individual Cogent Biosciences shareholder, owning 9.00M shares representing 6.32% of the company. Fairmount Funds Management LLC's Cogent Biosciences shares are currently valued at $313.14M.

If you're new to stock investing, here's how to buy Cogent Biosciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.